Related Experiment Videos
The non-ionic isotonic contrast agents. Perspectives and controversies
1Department of Diagnostic Radiology, Hammersmith Hospital, London, UK.
European Radiology
|January 1, 1996
Summary
New non-ionic, isotonic contrast agents offer excellent safety profiles for high-dose X-ray imaging. Their properties may improve image quality in various vascular imaging techniques.
Area of Science:
- Radiology and Medical Imaging
- Pharmacology
- Biomedical Engineering
Background:
- Introduction of a novel class of intravascular iodinated X-ray contrast agents.
- These agents are non-ionic, highly hydrophilic, and iso-osmolar with body fluids.
- Key characteristics include low chemotoxicity and elimination of Coulomb interactions.
Purpose of the Study:
- To evaluate the toxicity profile of non-ionic isotonic contrast agents.
- To assess the potential benefits of these agents in enhancing vascular imaging quality.
- To explore their suitability for high-dose imaging procedures.
Main Methods:
- In vitro testing and organ-specific toxicity studies.
- Systemic toxicity assessments, including LD50 measurements.
- Evaluation of imaging characteristics, such as diffusion across vessel walls.
Main Results:
- Demonstrated an excellent toxicity profile across all tested parameters.
- High-dose procedures are justified due to the agents' low toxicity.
- Iso-osmolality and molecular diffusion characteristics may enhance image quality.
Conclusions:
- Non-ionic isotonic contrast agents possess a favorable safety profile.
- Their properties suggest advantages for high-dose intravascular imaging.
- Potential for improved image quality in techniques like IV-DSA and CT arteriography.